
A 2026 analyst guide to FDA's 510(k), De Novo, and PMA pathways for AI-enabled medical devices, with a reproducible tabulation of FDA's own device list, PCCP adoption data, and peer-reviewed clinical evidence audits.
IntuitionLabs is now a member of the Claude Partner Network – AI training and upskilling with Claude for pharma and biotech. Book a call.

A 2026 analyst guide to FDA's 510(k), De Novo, and PMA pathways for AI-enabled medical devices, with a reproducible tabulation of FDA's own device list, PCCP adoption data, and peer-reviewed clinical evidence audits.

A 2026 guide to the FDA's AI-enabled medical device list: 1,524 entries reviewed this session, 510(k) versus De Novo pathways, radiology's 76 percent share, JAMA Health Forum evidence gaps, and landmark clearances including LumineticsCore and Aidoc CARE.

Analysis of FDA's December 2025 clearance of UpDoc K253281, the first SaMD using patient-facing LLMs in 2026, covering its 510(k) predicate strategy, PCCP, and data on 1,451 AI device clearances.
© 2026 IntuitionLabs. All rights reserved.